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Abstract
The Dystroglycan-Dystrophin (Dg-Dys) complex has a capacity to transmit information from the extracellular matrix to the
cytoskeleton inside the cell. It is proposed that this interaction is under tight regulation; however the signaling/regulatory
components of Dg-Dys complex remain elusive. Understanding the regulation of the complex is critical since defects in this
complex cause muscular dystrophy in humans. To reveal new regulators of the Dg-Dys complex, we used a model organism
Drosophila melanogaster and performed genetic interaction screens to identify modifiers of Dg and Dys mutants in
Drosophila wing veins. These mutant screens revealed that the Dg-Dys complex interacts with genes involved in muscle
function and components of Notch, TGF-b and EGFR signaling pathways. In addition, components of pathways that are
required for cellular and/or axonal migration through cytoskeletal regulation, such as Semaphorin-Plexin, Frazzled-Netrin
and Slit-Robo pathways show interactions with Dys and/or Dg. These data suggest that the Dg-Dys complex and the other
pathways regulating extracellular information transfer to the cytoskeletal dynamics are more intercalated than previously
thought.
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Introduction
Muscular dystrophies are a group of inherited neuromuscular
disorders that share the same basic phenotype of progressive loss of
muscle integrity. Many muscular dystrophies are caused by defects
in a specialized cell adhesion complex called the Dystrophin
Glycoprotein Complex (DGC). It has become evident that this
complex plays a central role in muscle integrity and forms a
mechanical link from the actin cytoskeleton to the extracellular
matrix (ECM). The core DGC is composed of a transmembrane
component, Dystroglycan (Dg), which associates with the ECM
protein, Laminin and the cytoplasmic protein Dystrophin which
binds Actin (reviewed in [1,2]).
Many lines of evidence confirm that maintaining the structural
link from the extracellular matrix to the actin cytoskeleton is
crucial in preventing many forms of muscular dystrophy.
Mutations that disrupt any component of this structural link
results in a variety of muscular dystrophies like Duchenne’s,
Becker’s, Muscle-eye-brain disease, Walker-Warburg syndrome,
congenital muscular dystrophies 1C and 1D as well as limb girdle
muscular dystrophy 2I. These diseases share the common
symptoms of skeletal muscle degeneration, cardiomyopathy, as
well as a reduced life span for afflicted individuals [3].
Additionally, alterations which reduce the affinity of compo-
nents of the DGC lead to congenital muscular dystrophies like
Fukuyama’s which, aside from muscular defects, also are
associated with aberrant neuronal migrations that lead to mental
retardation, epilepsy, as well as abnormal eye development. The
use of animal model systems has led to the clarification of the roles
of specific gene products in maintaining muscle integrity and
function (reviewed in [4]), however, the regulation of this complex
is largely unknown.
Initial characterization of the DGC in Drosophila has determined
that components studied so far possess similar roles in muscle
integrity and neuronal migration in flies as in humans (Figure 1,
[5,6,7,8]). These abnormalities include age dependent muscle
degeneration, reduced mobility, defects in eye development as
manifested by altered photoreceptor axon pathfinding, and a
shorter life span. Additionally, mutations in Dys and Dg affect cell
polarity in the Drosophila germ line as both the follicular cell
epithelium and the oocyte are disrupted [6,9,10]. Recently, a
reduced lifespan in Drosophila, as well as heart and muscle
abnormalities, have been reported in mutants of another
component of the DGC, d-sarcoglycan [5]. In addition, heart
and eye phenotypes have been observed in Drosophila Dys and Dg
mutants [11,12].
The similar defects in both flies and humans make Drosophila an
attractive model for further studies on clarifying the role of the
DGC. Such studies may reveal novel components that may likely
have counterparts in humans. Additionally, since very little is
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this heretofore unknown process. More recently, transmembrane
signaling has been implicated in the function of the DGC. The C-
terminus of Dystroglycan, in addition to having, EF and WW
domain binding sites, also possesses SH2 and SH3 domain binding
sites. These known protein-protein interaction motifs support the
idea that Dystroglycan is a signaling receptor in addition to its
known role as a conduit between the ECM and the cytoskeleton.
Changes in MAPK kinase and GTPase signaling have also been
observed when the DGC is perturbed [2,13]. Recent work has
shown that specific sets of domains are critical in the function of
Drosophila Dystroglycan [8].
In the present work, we have used the genetic tractability of
Drosophila to search for novel components of the DGC, as well as
components that may be involved in its signaling and regulation.
Such a search is straightforward because in addition to the muscle
degeneration and photoreceptor axon pathfinding defects, muta-
tions in dystrophin and Dystroglycan cause a visible phenotype
manifested as alterations in the fly wing, particularly the posterior
crossvein (Figure 2, [14]). Since this is an easily score-able, highly
penetrant phenotype we undertook a dominant modifier screen
approach and looked for flies that showed either a suppression of
the crossvein phenotype or a noticeably altered crossvein.
Importantly, crossvein development has been previously shown
to require EGFR, TGF-b and Notch pathway activities and is
therefore a sensitive place to observe potential interactions of the
DGC with these signaling pathways [15,16,17]. In addition,
hemocyte migration is shown to correlate with the crossvein
development [14]. Therefore genes involved in correct migration
processes might also be obtained by this approach. We screened P-
element lethal as well as deficiency collections for interactors in
addition to performing a classical ethylmethanesulfonate (EMS)
screen for dominant modifiers.
Here we report that in using these screening strategies we have
found modifiers that belong to six different functional groups. We
have found genes involved in muscle development, neuronal/cell
migration and motor function as well as cytoskeletal components
and components of the TGF-b, EGFR and Notch pathways. A
common theme among many of these interactors and Dg-Dys
complex is their involvement in the cytoskeletal rearrangements
controlled by extracellular cues.
Results
To identify genes that interact with Dys and Dg, we used the
chromosomal lesion hypomorph Dys
E6 as well as the RNAi
knockdown mutants Dys
N-RNAi, Dys
C-RNAi and Dg
RNAi. These
mutants exhibit age dependent muscle degeneration of indirect
flight muscles (IFM, Figure 1B and 1C) as shown before for other
Dys alleles [6].
In addition to the muscle phenotype, a visible wing vein
phenotype was observed in these and previously analyzed alleles.
In particular, the posterior crossvein (PCV) is defective in both Dys
and Dg mutants, a disrupted anterior crossvein (ACV) and a partial
duplication of L2, a longitudinal wing vein, can also be observed at
a lower frequency (Figure 2). These phenotypes are present in the
RNAi knockdown mutants, Dys
N-RNAi, Dys
C-RNAi and Dg
RNAi
(Figure 2C, 2D and 2E, respectively) as well as the chromosomal
lesion hypomorphs Dys
E6 (Figure 2B), DysDf, Dg
O43,D g
O55 and
Dg
O86 [14]. Dys and Dg are expressed in third instar larval wing
imaginal discs (Figure S1) and interact in the wing vein since the
double mutant shows a new phenotype – a duplication of L3
longitudinal wing vein (Figure 2F and 2F’).
We used the visual wing vein phenotypes in P-element lethal,
EMS induced and deficiency screens to find dystrophin and
Dystroglycan interactors in Drosophila that either increase or decrease
the wing vein phenotype. Additional studies reveal that many of
the interactors identified in the screens are required for proper
function in other tissues that require Dys and Dg, such as muscle,
brain and ovary.
Modifier Screens
To identify Dys and Dg interactors, we screened three different
kinds of mutants; a collection of 800 FRT-P-element lethal lines, a
deficiency collection of 216 lines and 43,000 EMS induced
mutants. From these analyses, we identified 37 interacting genes
that can be clustered into six different functional groups (Table 1).
P-element screen. We screened FRT-P-element lethal lines
from the Kyoto Stock Collection (Japan). The homozygous
lethality of the lines allows us to infer that the transposon is
inserted in or near an essential gene. We set up crosses to search
for modifiers of the RNAi mutants Dys
C-RNAi , Dys
N-RNAi and Dg
RNAi
as well as Dys
E6, a hypomorph that removes DLP2, a specific long
Figure 1. Muscle Phenotypes of Dys Mutants. Transverse histological sections of indirect flight muscles showing age dependent muscle
degeneration. Control muscle section from Df(3R)Exel6184/+ flies at 18 days of age do not show any type of abnormalities (A). While lower
penetrance and milder muscle degeneration phenotype is observed from RNAi knockdown of long forms of dystrophin (act-Gal4:UAS-Dys
N-RNAi/+ flies
at 18 days of age (B), KX43/Df(3R)Exel6184 and Dys8-2/KX43), a strong muscle degeneration phenotype is seen when all forms of dystrophin are
reduced (C; tub-Gal4:UAS-Dys
C-RNAi/+ flies at 12 days of age).
doi:10.1371/journal.pone.0002418.g001
Genetic Screens/DGC Modifiers
PLoS ONE | www.plosone.org 2 June 2008 | Volume 3 | Issue 6 | e2418isoform of dystrophin [7]. Modifiers were divided into phenotypic
classes of enhancers, suppressors and suppressors with extra wing
vein material (En, Su or Su+; Figure 3). From the P-element screen
we obtained 33 modifiers of the Dys phenotypes (Table 1), 25 of
which also showed interaction with Dg (Figure 4). Since the
identity of these genes is known, we were able to organize these
modifiers into 6 different functional categories (Table 1).
We were excited to find genes involved in both muscle and
motor/cytoskeletal function as these are processes in which Dys
and Dg are known to act (Table 1, functional group I; Figure 4). Of
the muscle category genes, muscleblind (mbl) was the strongest
suppressor in the wing vein. Weak suppressors of this group
included Calmodulin (Cam) and the nicotinic acetylcholine receptor a 30D
(nAcRa-30D) (Table 1, functional group I), though nAcRa-30D
strongly interacted with Dg (Figure 4). Cytoskeletal and motor
function genes (Lissencephaly-1 (Lis-1), Kinesin heavy chain (Khc),
Dynamitin (Dmn) and Fhos showed moderate to weak suppression
with dystrophin mutants (Table 1, functional group I).
Another intriguing functional group that interacts with Dg-Dys
complex includes genes known to be involved in neuronal
migration (Table 1, functional group II). This group is composed
of the genes which belong to Semaphorin-Plexin (Sema-1a, Sema-
2a), Slit-Robo (slit (sli), roundabout (robo), leak (lea) – a robo2 homolog,
Syndecan (Sdc)) and Netrin-Frazzlez (frazzled (fra)) pathways. In the
wing vein most of these genes were scored as moderate to weak
suppressors of the Dys RNAi mutants. Importantly, Sema-2a and fra
modify Dys
E6 (Table 1, functional group II; Figure S3). Sema-1a
was found to moderately enhance the Dys wing vein phenotype.
Using our Dg
RNAi mutant we found that robo and Sema-2a enhanced
the Dg phenotype and Sema-1a and lea (robo2) suppressed the Dg
phenotype (Table 1; Figure 4 and Figure S4). We have previously
shown that Dys and Dg function in the Drosophila Photoreceptor
axon pathfinding [6] in processes similar to Semaphorin-Plexin,
Slit-Robo and Netrin-Frazzled pathways.
Functional groups IV and V (Table 1) contain interactors that
belong to the TGF-b signaling pathway: Daughters against dpp (Dad),
decapentaplegic (dpp), thickveins (tkv) and EGFR signaling pathway:
kekkon-1 (kek1) and argos. Dad, dpp and kek1 were strong modifiers of
the Dg
RNAi mutant (Table 1; Figure 4 and S4) and Dad and tkv of
Dys
E6 allele as well (Table 1, functional group IV; Figure S3). It has
been known for some time that TGF-b, Notch and EGFR
pathways are necessary for proper wing vein development ([18];
reviewed in [19,20]). In fact, many novel factors of these pathways
have been identified through the analysis of wing vein mutants.
The longitudinal wing veins that begin to form during late larval
stages of development require EFGR and TGF-b signaling
pathways for proper fating of cells in the region [15,21].
Crossveins appear in late pupal stages of development and require
TGF-b signaling for formation and EGFR and Notch signaling for
final patterning [17]. The posterior crossvein is particularly
sensitive to different levels of TGF-b signaling and forms only
after the proper formation of the longitudinal veins.
The last functional group (Table 1, functional group VI) contains
a group of 12 genes with disparate functions. One enhancer, glial cells
missing (gcm), was identified. Three strong suppressors of this group
also interacted with Dys
E6,t h eDrosophila homolog of the homeodo-
main-interacting protein kinase (HIPK), kismet (kis)a n dl(3)L4092,
which contains a zinc-finger motiff. kis, deadlock (del), gcm, POSH and
wunen (wun) also strongly modified Dg
RNAi (Figure 4).
Figure 2. Dys and Dg are Required for Proper Wing Vein
Formation and Interact in the Process. In a wild type like wing (A,
genotype Dys
E6/+) there are 5 longitudinal veins (L1–L5). The anterior
cross vein (ACV) forms between L3 and L4 and the posterior cross vein
(PCV) forms between L4 and L5. (A’) Higher magnification of the region
of the wing that shows both cross veins, ACV and PCV. Dys
E6/Dys
E6
homozygotes show defects in cross vein formation (B). The PCV is
detached from L4 and L5 and at a lower frequency, the ACV fails to form
a connection to L4. (B’) Higher magnification of the image in B where
arrows indicate the altered ACV and PCV. Arrows indicate altered cross
veins. The RNAi mutant that knocks down long forms of dystrophin (act-
Gal4:UAS-Dys
N-RNAi/+) also shows a PCV mutant phenotype where the
cross vein fails to attach to L4 and L5 (C). (C’) Higher magnification of
the image in (C) where the arrow indicates the altered PCV. (D) Shows
the wing vein phenotype of the RNAi dystrophin mutant (tub-Gal4:UAS-
Dys
C-RNAi/+) that reduces the protein levels of all isoforms. Here the PCV
is drastically affected and there is extra vein material above L2. (D’)
Higher magnification of the image in (D) where the arrows indicate the
alterations. The upper arrow shows extra wing vein material above L2.
The lower arrow indicates an altered PCV. The RNAi Dystroglycan
mutant (tub-Gal4:UAS-Dg
RNAi/+) also shows a wing vein phenotype (E).
In this case we see a branch off the PCV as well as extra material above
L2. (E’) Higher magnification of (E) where the upper arrow shows extra
wing vein material above L2 and the lower arrow shows branching from
the PCV. Finally, Dys and Dg interact in the Drosophila wing as the
double mutant (tub-Gal4:UAS-Dys
C-RNAi/UAS-Dg
RNAi)s h o w san o v e l
phenotype (F, F’). The box indicates a thickened L3 vein. (F’) Higher
magnification of the box is shown in (F). Arrows indicate extra L3
longitudinal vein material. (G) Wild type L3 vein from the same region
as shown in (F’).
doi:10.1371/journal.pone.0002418.g002
Genetic Screens/DGC Modifiers
PLoS ONE | www.plosone.org 3 June 2008 | Volume 3 | Issue 6 | e2418Table 1. Modifiers of Dg-Dys Complex
Functional groups Gene name Allele(s) Function
act-Gal4: UAS-
Dys
N-RNAi/+
tub-Gal4: UAS-
Dys
C-RNAi/+ Dys
E6/+
1
Dg inte-
ractors
2
I. Muscle, motor
and cyto-skeleton
function
Dys Dys[EMS-ModE10] Dys-Dg complex - - En (S) +
Cam Cam[k04213] Calmodulin, muscle contraction Su (W) - -
mbl l(2)k04222b* muscle development; splicing; RNA
binding
Su (S) Su+ (S) -
mbl[E27]** Su (S) Su+ (S) - +
nAcRa-30D l(2)k14204* acetylcholine receptor; muscle
contraction
Su+ (W) Su+ (W) -
nAcRa-30D[EY13897]** Su+ (W) Su+ (W) Mod (W) +
Lis-1 Lis-1[k13209] Dynein binding, WD repeats - Su+ (M) - -
Khc Khc[k13219] Kinesin, microtubule motor - Su+ (M) - -
Dmn Dmn[k16109] Subunit in Dynactin complex - Su+ (M) - -
Fhos l(3)j5B6 Actin organizing protein Su (M) Su+ (W) -
II. Neuro-nal
migration or planar
cell polarity genes
sema-2a sema-2a[k13416] ligand of PlexinB, axon guidance Su (W) Su+ (W) Mod (M) +
sema-1a sema-1a[k13702] axon guidance En (M) En (M) - +
fra l(2)k03003* receptor of Netrin Su+ (M) Su+ (M) Mod (W)
fra[4]** Su (W) Mod (W)
sli l(2)k02205* ligand (interects with Robo and Sdc) Su (W) Su+ (W) Mod (W)
sli[2]** Su (W) Su+ (W) - -
robo robo[2]** receptor Su (W) Su+ (W) - +
robo2 lea[2]** receptor Su+ (W) - +
Sdc l(2)k10317* Heparan sulphate proteoglycan
(interacts with Sli and Robo)
Su+ (S) Su+ (M) -
Sdc[10608]** Su+ (M) Su+ (W) - +
stan stan[129]** Receptor, Flamingo Su+ (M) Su+ (W) - +
wg wg[spd-1]** ligand Su+ (S) Su+ (S) Mod (M) +
grh grh[s2140] transcription factor Su+ (S) Su+ (S) Mod (W) +
III. Notch signaling Dl Dl[EMS-Mod130] ligand of Notch Su+ (S) Su+ (M) Mod (S) +
Dl[EMS-Mod140] Su+ (S) Su+ (M) Mod (S) +
IV. TGF-b signaling Dad Dad[j1E4] negative regulator Su+ (S) Su+ (S) Mod (M) +
dpp dpp[KG08191] TGF-b homolog Su+ (M) Su+ (W) - +
tkv tkv[k16713] type I receptor - - Mod (M)
msk msk[EMS-Mod90] importin En (S) En (S) En (S) +
msk[5]** Su (W) Su+ (M) +
V. EGFR signaling kek1 kek1[k07322] repressor of EGFR signaling Su+ (S) Su+ (M) - +
argos l(3)j10E8* repressor of EGFR signaling; ligand Su+ (W) - -
argos[Delta7]** Su+ (S) - - +
VI. Other Nrk Nrk[k14301] receptor tyrosine kinase Su (W) Su+ (M) - -
HIPK CG17090 [BG00855] serine/threonine kinase, death Su+ (S) Su+ (S) Mod (S) -
kis kis [k13416] ATP helicase activity; chromatin binding Su+ (S) Su+ (S) Mod (W) +
gcm gcm[KG01117] transcription factor activity En (S) En (M) - +
CG4496 CG4496[KG10365] zinc ion binding, nucleic acid binding Su (S) Su+ (S)
wun wun[k10201] lipid phosphate phosphatases - Su+ (W) - +
l(2)k11120a* Su+ (W) - -
POSH POSH [15815] SH3 adaptor protein, JNK signaling Su (W) Su+ (M) - +
vimar vimar[k16722] Ral GTPase binding Su (W) Su+ (M) - +
del del[KG10262] oogenesis - Su+ (S) +
SP1070 Poly-EGF [EMS-Mod29] Notch binding (predicted) Su+ (M) Su+ (M) -
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collection, we also screened for the Dys interactors using a
collection of deficiency lines, which covers about 30% of the 1st,
40% of the 2nd and 80% of the 3rd chromosome and found 10
regions on the 2nd and the 3rd chromosomes that interacted with
Dys
N-RNAi in the wing vein (Figure 5A). Nine of these deficiencies
suppressed the Dys PCV phenotype with formation of extra wing
vein material and belonged to the Su+ class (Figure 3C and 5B)
and one to the En class (Figure 3D and 5B). The wg and stan
(Flamingo, Fla) genes, which belong to the planar cell polarity
pathway (Table 1), were identified as Dys
N-RNAi interactors in
[27D1-27F2] and [47A7-47C6] cytological regions respectively
(Figure 5B). Both of these genes modify Dg
RNAi phenotype in wing
vein as well (Figure 4). A third component of the planar cell
polarity pathway, grainy head (grh), was identified from the P-
element screen. Furthermore, dystrophin and Dl genes located in
region [91F12-92A11], as well as poly-EGF and CG4496 from
[27D1-27F2] region were also independently identified in the P-
element and EMS screens (Figure 5B and Table 1).
EMS mutagenesis screen. We analyzed ,37,000 chromo-
somes for modifiers of Dys
N-RNAi and Dys
N2-RNAi and over 6000
chromosomes for enhancers of Dys
E6 and isolated 27 modifiers
(Table S1). Eighteen of these were localized to the 2nd
chromosome and nine were localized to the 3rd chromosome.
The genes defective in eight of these mutants were identified and
shown to correspond to five genes (Table 1). The modifier screens
using EMS produced similar phenotypes to those observed in the
P-element screen (Figure 4) and additionally produced a ‘‘posterior
crossveinless’’ class (14/27 modifiers; Figure S2). These modifiers
may be alleles of the crossveinless genes on the second and third
chromosomes. There are eight previously identified crossveinless
loci, cv, cv-2, cv-3, cv-b, cv-c, cv-d, cvl-5 and cvl-6. Two, cv and cvl-6,
are on the X chromosome. One, cv-3 is on the second chromo-
some and the remaining five are on the third chromosome.
Modulators of the TGF-b pathway are encoded by two of the eight
crossveinless loci, cv and cv-2. Of the remaining six one other, cv-c has
been molecularly characterized and encodes a Drosophila Rho
GTPase Activating Protein. The others may also encode effectors
of TGF-b signaling. Nevertheless, when cv and cv-2 are lost the
resultant aberrant TGF-b signaling results in the loss of both
crossveins. Of our crossveinless like modifiers, one, Mod90
(Table 1 and Table S1), was mapped to cytological location
66B, two map units distal to the hairy gene, and so does not appear
to be an allele of any of the crossveinless genes on the third
chromosome. An attractive candidate for this gene is moleskin (msk)
which encodes Drosophila Importin-7, a protein involved in nuclear
translocation that has been shown to regulate the TGF-b pathway
by controlling Mad localization. We further confirmed that
moleskin (msk
5) interacts with Dg and Dys (Table 1).
The next largest class of modifiers (9/27 EMS induced
modifiers; Table S1) belonged to the Suppressor+ (Su+) class with
extra wing vein material (Figure 3) and showed a more global
effect on the wing. Four of these modifier mutants, Mod59,
Mod111, Mod130 and Mod140, had phenotypes in the absence of
Figure 3. Wing Vein Phenotypes in Dys Modifier Classes. The
posterior cross vein (PCV) was used in the screening process. The Dys
mutant is depicted schematically in (A) with an actual fly wing (act-
Gal4:UAS-Dys
N-RNAi/+) shown to the right. Among the modifiers from the
originalmutant phenotypewas the Suclass orthe completelysuppressed
class (B) where the PCV reverted to the wild type cross vein. Another class
ofinteractorssuppressedthedetachedPCVphenotypebutalsoproduced
extra vein material, either as a branch or as an extra L2 vein (arrows, C).
This group was classified as suppressor-plus (Su+). Finally, a group of
modifiers showed a complete loss of the PCV (D, arrow) and this group
was classified as enhanced (En).
doi:10.1371/journal.pone.0002418.g003
Functional groups Gene name Allele(s) Function
act-Gal4: UAS-
Dys
N-RNAi/+
tub-Gal4: UAS-
Dys
C-RNAi/+ Dys
E6/+
1
Dg inte-
ractors
2
CG7845 CG7845[EMS-Mod4] WD40 domain protein Su+ (M) Su+ (M) -
l(3)L4092 l(3)L4092 Zn-finger protein Su+ (S) Su+ (S) Mod (S)
*, P-element insertion used in screen that may affect gene;
**, gene allele from Bloomington stock center; S, suppressor; Su+, suppressor of PCV with extra wing vein material; En, enhancer; Mod, modifier; (W), weak; (M),
moderate; (S), strong; 1, phenotypic classes shown in Figure S3; 2, summary for the data in Figure 4; +, interact; -, does not interact.
doi:10.1371/journal.pone.0002418.t001
Table 1. cont.
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PLoS ONE | www.plosone.org 5 June 2008 | Volume 3 | Issue 6 | e2418Figure 4. Dg Mutant Modifiers. The RNAi Dystroglycan mutant modifiers were scored either as an increase in penetrance of the Dg phenotype, or
as an addition of extra vein material. These are represented in a bar graph. The ordinate indicates the percent penetrance of the wing vein
phenotype. The abscissa indicates the genes that interact with tub-Gal4:UAS-Dg
RNAi/+ as heterozygotes. The unmodified Dg mutant phenotype is at
the far left (control) and shows that nearly 30% of Dg
RNAi/+ flies show the Dg mutant phenotype (orange color) with the rest having wild type wing
veins (yellow color). Modifiers that show an extra vein material are indicated in brown. Wing vein phenotypes are shown in Figure S4.
doi:10.1371/journal.pone.0002418.g004
Figure 5. Deficiency Screen. (A) Cytological map of 2nd and 3rd chromosomes. Red bars represent cytological regions that were screened for
interaction with Dys in wing vein. Blue bars represent deficiencies tested in the screen. Deficiences that showed interactions are circled in red.
Numbers next to the blue bars indicate deficiencies used to narrow down the Dys interacting region. (B) Numbers in column 1 describe the
deficiencies used to narrow down region and respond to the following deficiencies: (1) w
*; Df(2L)spd
j2,w g
spd-j2, (2) w
1118; Df(2L)ade3, (3) Df(2L)ED1473,
(4) Df(2R)ED2098, (5) Df(2R)en-B, b
1 pr
1, (6) Df(2R)en-A, (7) Df(2R)PC4, (8) y
1w
*/Dp(1;Y)y
+; Df(2R)P34, (9) Df(3L)ED4978, (10) Df(3R)ED5612, (11)
Df(3R)ED5942, (12) Df(3R)ED6025, (13) Df(3R)ED6069, (14) Df(3R)ED6076, (15) Df(3R)ED6265, (16) Df(3R)Tl-P, e
1 ca
1. Class of wing vein phenotype
modifiers is listed in second column. Cytology of 10 Dys interacting regions found in the screen is shown in column 3. Column 4 indicates Dys
interacting genes found in deficiency, EMS (*) and P-element (**) screens.
doi:10.1371/journal.pone.0002418.g005
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92A and showed that they are tightly linked to the Delta gene (Dl,
Table 1). Subsequent crosses to different Dl alleles yielded lethal
phenotypes, suggesting that these mutants are alleles of Dl. Two of
the modifiers Mod130 and Mod140 suppressed the posterior
crossvein phenotype of Dys
N-RNAi, i.e. formed a complete crossvein
from longitudinal vein L4 to longitudinal vein L5, in addition to
generating extra wing vein material. We also found modifiers that
belonged to the Enhancer as well as the Suppressor classes (Text
S1).
Two other members of the class of mutants with extra wing vein
material (Table S1 and Figure S2B), Mod4 and Mod29 were
mapped to specific locations on the 2nd chromosome. Mod4 was
mapped by following its lethality phenotype in crosses with
deficiency lines. It was lethal in a cross with the Df(2R)nap9/
Dp(2;2)BG, In(2LR)Gla line and was not lethal in a cross with the
Df(2R)ST1, Adh[n5] pr[1] cn[*]/CyO line. The available lethal
mutants from cytological region 42A1-42B3 were crossed to Mod4
and using a P-element insertion line, PBac{PB}CG7845c00845/
CyO we determined that the mutation was in gene CG7845. This
gene codes for a WD40 containing protein whose function is not
known (Table 1). The underlying common function of all WD-
repeat proteins is coordinating multi-protein complex assemblies,
where the repeating units serve as a rigid scaffold for protein
interactions. Such a scaffolding protein may be utilized in the
formation or stabilization of the DGC.
Following the wing vein phenotype seen in homozygous flies as
well as its semi-lethality, Mod29 was mapped to cytological region
27D1-27D4. This region was independently identified to contain a
Dys interactors through the Deficiency screen (Figure 5B). We
further fine-mapped the region by showing that two smaller
deficiency lines, Df(2L)ade3/CyO,P{ftz/lacB}E3 and Df(2L)Ex-
el7029,P+PBac{XP5.WH5}Exel7029/CyO phenocopy the semi-
lethality/wing vein phenotypes seen with Mod29. Ultimately,
Mod29 was determined to be a poly-EGF gene mutant. Other
genes in the region were eliminated by complementation analysis.
In addition to the wing vein phenotype, Mod29 also shows defects
in muscles, in oogenesis and in the brain (photoreceptor axon
termination; Figure S5). Additionally, these mutant animals have a
very short lifespan. Since Poly-EGF is predicted to bind the Notch
receptor further functional analysis will be very interesting.
As discussed above, the Dys
E6 mutant does not show a wing vein
phenotype as a heterozygote (Figure 2A). But as a homozygote it
displays a disrupted posterior crossvein similar to Dys
N-RNAi
(Figure 2B and 2C). We reasoned that this heterozygote
background was ‘‘sensitized’’ and therefore excellent for identify-
ing enhancers. We screened 6000 chromosomes and found four
modifiers for Dys
E6/+. Three of those modifiers showed some extra
wing vein material in the posterior crossvein (Figure S2B). Two of
the modifiers, on the third chromosome ModE21 and ModE26
showed a branched crossvein phenotype in the absence of Dys
E6
though this dominant phenotype was not completely penetrant.
The third of this group, ModE11 on the second chromosome,
showed no wing vein phenotype in the absence of Dys
E6, however
as a homozygotes ModE11 flies displayed a globally disrupted
wing vein characterized by an abundance of extra vein material
(data not shown). Modifier E10 was the only modifier that showed
an enhanced phenotype (Figure S3A). ModE10/Dys
E6 flies
phenocopied the Dys
E6 homozygous phenotype which is a
reduction in wing vein material (Figure 2B). Moreover,
ModE10/Df(3R)Exel6184 flies also gave a similar wing vein
phenotype to Dys
E6/Df(3R)Exel6184 flies strongly arguing that
ModE10 is a dystrophin allele. Finding an additional allele of Dys
confirms that the screening approach was successful and analysis
of the EMS mutant will allow us to further characterize
Dystrophin protein function. Furthermore, the newly identified
dystrophin allele ModE10 interacted strongly with the Dg RNAi
mutant in the wing; instead of 27% penetrance, the phenotype was
96% penetrant in heterozygous Dys[Mod-E10] background
(Figure 4). This further confirms that molecules acting closely
with Dys and Dg can be found in this assay.
mbl Interacts with Dys in Muscles
These modifier screens led to the identification of genes that
belong to different functional groups. Importantly, genes with
known muscle function were identified in this screen, including
dystrophin itself. In addition, the screen also identified muscle genes
previously shown to interact with the Dg-Dys complex, Cam, mbl
and nAcRa-30D [22,23,24]. muscleblind encodes a RNA binding
protein that has shown to function in splicing [25]. As part of a
secondary screen in muscle tissue, we tested whether mbl, a strong
interactor with Dys in wing vein, also interacts with Dys in the
indirect flight muscles.
Animals that have lost one copy of mbl appear to have normal
muscle structure (Figure 6A), while act-Gal4:UAS-Dys
N-RNAi mutants
show moderate muscle degeneration (10 days old: 10%, n=68;
18 days: 25%, n=159; Figure 6B and 6D). However, the extreme
muscle degeneration phenotype was not observed in 10 days old
and at a low frequency in 18 day old Dys
N-RNAi mutants (Figure 6B
and 6D). In contrast, when mbl was reduced by one copy in a Dys
N-
RNAi mutant background, increase in muscles defects was observed.
Furthermore, around 50% of the phenotypes observed were
classified ‘‘extreme’’ both in 10 and 18 day timepoints (Figure 6C
and 6D). These data suggest that mbl and Dys interact in the
muscles and reduction of muscleblind level enhances the abnormal
muscle phenotype in Dys
N-RNAi mutants. These results show that
the screen successfully identified genes that interact with dystrophin
to establish normal muscle function.
Interactors Show Germline Phenotypes Similar to Dys
and Dg Mutants
The Dys and Dg genes are required in the germ line for the
establishment of oocyte polarity [6,8,9]. The oogenesis defects of
Dys and Dg serve as an excellent test to identify whether the new
modifiers might interact with Dg-Dys complex in other tissues as
well as in wing development. The ovariole contains a progression
of egg chambers at different stages of development (Figure 7A). An
early oocyte polarity marker, Orb, is localized to the anterior side
in early stages and then migrates to the posterior side of oocyte by
stage 3 of oogenesis. Between stages 3 and 6, Orb is clearly
localized to the posterior of the oocyte, making it an excellent
marker to analyze the polarity of the oocyte (Figure 7A–B). Dg loss-
of-function germ line clones and homozygous point-mutants are
arrested at early stages of oogenesis ([9]; Figure 7B) and show
mislocalization of the Orb marker that is usually missing or
diffused ([9]; Figure 7D). The oocyte polarity phenotype was also
observed for viable Dg and Dys alleles (Figure 7B, 7D and 7E; 74%,
n=50 for Dg
O86/Dg
O55, 82%, n=34 for Dg
O43/Dg
O55 and 68%,
n=48 for Dg
O86/Dg
O43; the ovaries were dissected from 12 days
old mutants).
Interestingly, many of the identified modifiers are genes
previously shown to be required in germ line development. For
example a scaffolding protein, Rack1 that contains multiple WD-
domains and interacts with atypical protein kinase C (aPKC) has
recently been shown to function during Drosophila oogenesis [26].
We now analyzed potential Rack1 function in germ line for
posterior Orb localization. Importantly, this analysis revealed that
Rack1 is required in the early oocyte polarity: lack of Rack1 in
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eggchambers (76%, n=13, Figure 8H). Consistent with these
findings aPKC is required for early oocyte development in
Drosophila [27]. Similarly, another Dys and Dg interacting protein,
Deadlock has previously shown to be required for Orb localization
[28]. It is, therefore, likely that other identified Dys and Dg
interactors are required in early oocyte polarity, possibly in a
process closely related to Dg-Dys function in oogenesis.
Utilizing the FRT sites in the P-lethal lines we made germ line
clones to determine how many of the selected modifiers had a role
in the establishment of early oocyte polarity. We analyzed germ
line clones of 14 loss-of-function mutants and found 8 genes that
showed a similar phenotype to that seen in Dg loss-of-function
clones. One of these genes, POSH, is an SH3 adapter protein.
Loss-of-function clones of POSH (Figure 8A, white arrow) were
arrested prior to stage 3–4 of oogenesis and appeared to lack Orb
entirely. Orb mislocalization was also found in Sema-2a, kek1, kis,
Lis-1, chif and Khc. Sema-2a loss-of-function clones showed clear
developmental arrest prior to stage 4–6 with diffused Orb staining
(Figure 8B). kek1, a negative regulator of the EGFR pathway, also
showed developmental arrest in loss-of-function clones (Figure 8C).
Orb in kek1 clones surround the oocyte in an irregular pattern. kis
loss-of-function germline clones have shown developmental arrest
and diffused Orb staining (Figure 8D). Similarly, the majority of
Lis-1, chif and Khc germline clones showed abnormal Orb
localization (Figure 8E–8G). Lis-1 and Khc have previously shown
to be involved in oocyte microtubular motor activities and to
interact in this process [29,30].
These data indicate that many of the genes that showed
interactions with Dys and/or Dg in the wing vein assay, also
showed early oocyte polarity phenotypes similar to Dys and Dg and
potentially play a role in the establishment of early oocyte polarity.
Discussion
In mammalian systems the DGC is composed of Dystrophin,
Dystroglycan, the Sarcoglycan complex (a, b, c, d, e, and f),
Sarcospan, the Syntrophins (a and b), the Dystrobrevins (a and b)
and Caveolin-3 [2]. Presently, the regulation of Dg-Dys complex
and its involvement in signaling are poorly understood. In this
work, we have addressed these unknowns by using dominant
modifier screens to find genes that may shed light on both of these
processes. Our screens have revealed groups of modifiers that are
components of canonical signaling pathways (TGF-b, EGFR, Wnt
and Notch) as well as components involved in cell/neuronal
migration, cytoskeletal rearrangements and most importantly
muscle development.
New Components of the Dg-Dys Pathway?
The screens described in this paper revealed some expected
interactors, Dys, Cam and Khc. Calmodulin, a calcium binding
protein required for muscle and neuronal functions has previously
been shown to interact with mammalian the Dg-Dys complex.
However, whether reduction of Cam activities suppresses or
enhances the muscular dystrophy phenotype is not totally clear.
Targeted inhibition of Cam signaling exacerbates the dystrophic
Figure 6. mbl Interacts with Dys in Muscle. (A–C) Transverse histological sections of indirect flight muscles of 18 days old flies. Reduction of
muscleblind by one copy does not show obvious muscle defects (A). A stronger phenotype is observed in a act-Gal4:UAS-Dys
N-RNAi/+ mutant where
loss of muscle integrity is noticeable throughout the tissue (B) and a significantly higher level of muscle degeneration is observed if the level of
muscleblind is reduced in a Dys mutant background (act-Gal4:UAS-Dys
N-RNAi/mbl, C). A green arrows in B and C indicate moderate muscle
degeneration and blue arrows extreme muscle degeneration phenotype. The bar graph (D) quantifies the percentage of muscles that yielded the
muscle phenotypes in 10 and 18 days old flies. Green bars indicate moderate muscle degeneration and blue arrows extreme muscle degeneration
phenotype.
doi:10.1371/journal.pone.0002418.g006
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Calcineurin improves skeletal muscle pathology and cardiac disease
in a ¨-sarcoglycan null mice [31,32]. Since reduction of Cam showed
suppression of the phenotypes caused by reduction of the long
forms of dystrophin in the Drosophila wing, it will be interesting to
analyze whether reduction of Cam will suppress the Drosophila Dys
muscle phenotype as well. Khc involvement in Dg-Dys complex is
also expected since work in mammalian system has shown that
Khc can bind Dystrobrevin, a component of Dg-Dys complex
[33]. It will be interesting to test in the future whether Drosophila
Dystrobrevin can similarly bind Khc and what the functional
significance of this interaction is in muscles and neurons. We have
already shown that in oocyte development Khc is required for the
same early as Dys and Dg (Figure 7). It is, therefore, interesting to
test the potential requirement of dystrobrevin in this process and to
further dissect the Khc function in this complex during early
polarity formation.
An unexpected new interactor was identified in our screens, the
homeodomain interacting protein kinase, HIPK. In mammalian
systems HIPK is involved in the cell death pathway by
phosphorylating p53 [34]. Recently Drosophila HIPK has shown
to be involved in a communal form of cell death, sudden,
coordinated death among a community of cells without final
engulfment step [35]. It remains to be seen whether this HIPK
communal death pathway will utilize p53 phosphorylation.
However, it is tempting to speculate that the cell death observed
in muscular dystrophies use the newly described HIPK dependent
communal death pathway. HIPK is shown to interact with a
WD40-protein in mammalian system [35]. Since three WD40
proteins were identified in our screens, it will be interesting to test
whether any of these interact with Drosophila HIPK.
Another interactor that might shed light in the pathways utilized
by the Dg-Dys complex is an SH3-domain adapter-protein,
POSH. Structure-function analysis of Dg protein has revealed that
a potential SH3-domain binding site in Dg C-terminus is essential
for Dg function [8]. However, the critical SH3-domain protein in
this complex is still at large. The present screen revealed that
POSH can interact with the Dg-Dys complex in the wing vein
assay. It will now be interesting to determine whether POSH is the
missing critical SH3-domain protein that interacts with Dg-Dys
complex in Drosophila.
The Neuronal/Cell Migration Pathways Interact with the
DGC
There are only a few examples of signaling pathways that have
been shown to transmit information from outside the cell that
results in cytoskeletal rearrangements inside the cell. Slit-Robo,
Netrin-Frazzled and Semaphorin-Plexin pathways are examples of
such activity. Dg-Dys complex appears also regulate the
cytoskeleton based on extracellular information. Interestingly,
the interaction screens described in this paper show that these
aforementioned pathways are much more intricately connected
than previously thought. The Robo and Netrin Receptor (DCC)
pathways have previously been shown to interact [36], now we
report that Dg-Dys complex interact with these pathways as well.
The interactions that we see in wing development involving the
Drosophila DGC and the genes that affect neuronal guidance (sli,
robo, fra, sema-2a, sema-1a, Sdc) might be explained by their possible
role in hemocyte (insect blood cell) migration. Analysis done in
Drosophila shows that known axon guidance genes (sli, robo) are also
implicated in hemocyte migration during development of the
central nervous system [37]. Similar findings have been reported
in mammals, where blood vessel migration is linked to the same
molecular processes as axon guidance [38]. Both sli and robo have
been implicated in the vascularization system in vertebrates [39].
A recent study demonstrated that proper hemocyte localization is
dependent upon Dys and Dg function in pupa wings. Mutations in
these genes result in hemocyte migration defects during develop-
ment of the posterior crossvein [14]. Hence, we speculate that the
neuronal guidance genes that we have found may interact with the
DGC in wing veins by having a role in the migration process.
Similar to sli and robo [40], the Dys and Dg mutants also affect
photoreceptor axon pathfinding in Drosophila larvae [6]. It is
therefore possible that this group of modifiers will interact with the
DGC in axon pathfinding and other processes. Supportive of that
notion is the fact that mammalian Syndecan-3 and Syndecan-4
are essential for skeletal muscle development and regeneration
[41]. In addition slit-Dg interaction has previously been observed
in cardiac cell alignment [42]. Sequence analysis of slit reveals that
it possesses a laminin G-like domain at its C-terminus. Dystrogly-
can’s extracellular domain has laminin G domain binding sites and
has been shown to bind 2 of the five laminin G domains in
laminin. It is therefore possible that slit, through its laminin G-like
domain, binds to Dystroglycan and that Dystroglycan is a slit
Figure 7. Dys and Dg Mutant Germline Phenotype. In the wild
type ovariole, Orb localizes to the posterior of stage 3–6 oocytes (A, B).
(C) In Dg
O55 mutants, however, there is mislocalization of Orb and much
degeneration is observed. Arrowheads indicate mutant egg chambers.
Additional analyses of Dg
O86/Dg
O55, Dg
O43/Dg
O55 and Dg
O86/Dg
O43 show
similar phenotypes (not shown). Stage 3–6 wild type egg chambers
show posteriorly localized Orb staining (D, arrowheads, red staining).
(D’) shows Orb staining alone. Stage 3–6 Dg
O55 mutant egg chambers
show an abnormal lateral localization of Orb (E, arrowheads, red
staining). (E’) shows Orb staining alone. Stage 3–6 egg chambers from
DysDf homozygotes where the Orb staining is defused. (E’) more clearly
shows the altered Orb staining.
doi:10.1371/journal.pone.0002418.g007
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nature of these interactions.
Oocyte Phenotypes
The establishment and formation of oocyte polarity during
development is a complex multistep process (reviewed in [43]). In
the anterior part of the germarium each stem cell undergoes
asymmetric cell division to give rise to another stem cell and a
cystoblast. The cystoblasts divide four times with incomplete
cytokinesis to form a 16 cell cyst. The oocyte fate is determined
when the cyst reaches the end of the germarium. At this point,
BicD protein, Orb protein, the microtubule organizing center
(MTOC) and the centrioles move from the anterior to the
posterior of the oocyte (Figure 7A). These events mark the first sign
of polarity in the oocyte. Subsequent Gurken signaling induces
posterior follicle cells to signal back to the oocyte which repolarizes
the microtubule cytoskeleton. This signal appears to require an
intact extracellular matrix since Laminin A mutants do not undergo
repolarization [44]. The outcome of the repolarization results in
the disassembly of the MTOC at the posterior, nucleation of
microtubules anteriorly and subsequent migration of the oocyte
nucleus to an antero-lateral position.
Germ line clones that lack Dg show developmental arrest and
mislocalization of the oocyte polarity marker Orb which is usually
diffused or absent in the oocyte [9]. This phenotype might be due
to Dg affecting the localization of the MTOC. But how exactly Dg
is involved in this process is not clear. One possible explanation is
that Dg is required for extracellular matrix (ECM) integrity since it
is known to bind Laminin. Such a structural conduit may be
necessary for proper signaling from the posterior follicle cells to the
oocyte. This is supported by the fact that Dg loss-of-function
mutants show defects in Actin accumulation. Another possibility is
that Dg may be involved in mircrotubule organization. Since the
regulation of actin- and microtubule-cytoskeleton are connected,
these two models are not mutually exclusive.
Interestingly, in our screens we found several genes that showed
phenotypes in oocyte development. One of these genes is kek1,a
transmembrane protein of the Drosophila Kekkon family that has
been reported to be a negative regulator of the EGFR receptor
[45]. It has been previously shown that EGFR signaling regulates
Figure 8. Interactors Show Similar Germ Line Phenotypes to Dys and Dg. POSH (hsFlp, FRT42D), loss of function clones show arrest at around
stage 3–4 and appear to lack Orb staining completely (A). Loss of function clones of Sema-2a (hsFlp, FRT42D Sema-2a[k13416]) (B), kek1 (hsFlp, FRT40A
kek1[k07322]) (C), kis (hsFlp, FRT40A kis[k13416]) (D), chif (hsFlp, FRT40A chif[BG02820]) (E), Khc (hsFlp, FRT42D Khc[k13219]) (F), Lis-1 (hsFlp, FRT42D Lis-
1[k13209]) (G) and Rack1 (hsFlp, FRT40A Rack1[EY00128]) (H) all show developmental arrest prior to stage 6. Khc, like POSH appears to lack any Orb
staining (red) while the others have abnormal Orb staining ranging from punctate (Sema-2a) to completely surrounding the oocyte (chif and Rack1).
GFP, green; Orb, red; DAPI, blue in (A–H). (A’–H’) show GFP staining. Arrows indicate Orb staining in clones.
doi:10.1371/journal.pone.0002418.g008
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posterior polarity of oocyte [10]. Further study is required to
determine if kek1, as an EGFR regulator controls Dg expression in
the germ line.
Another interesting gene found in our screens is POSH (Plenty of
SH3 domains), a Drosophila homologue of human SH3MD2
protein. Interestingly POSH is a multidomain scaffold protein that
can interact with Rho related GTPase - Rac1 and promotes the
activation of the JNK pathway [46] POSH has also shown to
regulate POSH-MLK-MKK-JNK complex [47]. A defect in this
complex can affect brain function. Furthermore, POSH and JNK-
mediated cell death pathway is thought to play an important role
in Parkinson’s disease [48]. With many SH3 domains, POSH has
the potential to bind Dg that has a predicted SH3-domain binding
site and has been shown to be necessary for the establishment of
oocyte polarity [8].
In addition, we have found interactions with Khc, Lis-1 and Dmn,
three genes known to be part of the Dynein-Dynactin complex
which in addition to Kinesin microtubule motor activity have been
shown to be necessary for establishment of intracellular polarity
within the Drosophila oocyte [49,50]. In mid-oogenesis dynein,
dynactin and kinesin are thought to act cooperatively in cargo
transport [49,51,52]. Since these genes interact with Dys (Table 1)
and show similar phenotypes in Orb localization (Figure 7), it will
be interesting to dissect their potential functional interactions with
Dys in early oocyte development. Furthermore, since mammalian
Dystrobrevin physically interacts with Khc, it is plausible, that the
Dynein-, Dynactin-, Kinesin-complex will utilize localization cues
set-up by Dg-Dys Complex.
In addition to the interactions with microtubular motor-
complexes, we also found interactions with a Drosophila Formin
homologue, FHOS. Mammalian FHOS directly binds to F-actin
and promotes actin fiber formation [53]. Recently Drosophila actin
nucleators, Capu and Spire have shown to assemble a cytoplasmic
actin mesh that maintains microtubular organization in the middle
of oogenesis [54,55,56,57,58]. Therefore, it will be important to
determine whether the actin nucleator, FHOS is also involved in
actin nucleation that regulates microtubular activity in early
oocyte development. Further study of these cytoskeletal genes will
allow us to gain a more detailed understanding of how Dg and Dys
function to ensure proper oocyte polarity during oogenesis.
Similar to microtubule and actin interplay in the regulation of
oocyte polarity, the dynamic actin-microtubule interactions
regulate growth cone steering at the growing axons [59]. It is
therefore possible that similar mode of function for Dg-Dys
interactions with these cytoskeletal modules is used in various cell
types. Furthermore the axon pathfinding and oocyte polarity
formation processes are similar in that they are controlled by
extracellular information which is transmitted to the cell resulting
in cytoskeletal rearrangement.
Planar Cell Polarity Genes
At the basal side of follicle epithelium, actin filaments exhibit a
planar cell polarity that is perpendicular to the long axis, the AP
axis, of the egg chamber. In Dg follicle cell clones the basal actin
array is disrupted non-cell-autonomously [9]. Integrins and the
receptor tyrosine phosphatase Lar are also involved in basal actin
orientation [60]. It is unclear whether Dg and the other genes
involved in basal actin polarity act together with the canonical
planar cell polarity pathway or function independently of this
pathway. Interestingly, we now report strong interactions between
the DGC and grainy head (grh) a transcription factor which is
required for several different processes during the differentiation
including the function of the frizzled dependent tissue polarity
pathway, epidermal hair morphogenesis and wing vein specifica-
tion [61]. In the absence of grh function the Fz, Dsh and Vang
proteins fail to accumulate apically and the levels of Stan (or
Flamingo) protein are dramatically decreased. The interactions
seen with stan (Fla) and wg in wing veins supports the hypothesis
that Dg might act together with the frizzled-dependent tissue
polarity pathway in coordinating the polarity of cells in epithelial
sheets.
Conclusions
By screening for alterations of a dominant wing vein phenotype
we have found modifiers of the DGC that are involved in
cytoskeletal organization. Initial characterization of some of these
genes revealed that they have phenotypes also in other tissues, in
which the DGC is known to function. These tissue/cell types
include the oocyte, the brain and the indirect flight muscles. This
argues strongly that the identified interactors may be involved
globally in DGC function. Further study is required to determine
mechanistically how these modifiers work in the context of the Dg-
Dys complex. However a common theme, already arising is that
the identified interactors appear to regulate cytoskeletal rear-
rangement. Mechanistic understanding of how the new interactors
might regulate Dg-Dys communication with cytoskeleton of
muscle cells may serve as a basis for the development of novel
therapeutic approaches that might improve the quality of life of
individuals afflicted with muscular dystrophy.
Materials and Methods
Fly Strains and Genetics
The fly-strains used is in this study are: Dys
E6/TM3, UAS-Dys
N-
RNAi/CyO (both kindly provided by L.Fradkin and described
previously as dys
DLP2 E6 and RNAi-dysNH2 [62]), UAS-Dys
N2-RNAi/
TM3, UAS-Dys
C-RNAi/TM3, UAS-Dg
RNAi/TM3 (described previ-
ously as UASdsDysN-term, UASdsDysC-term and UASdsDg, respec-
tively [6]), DysDf, Dg
O43/CyO, Dg
O55/CyO, Dg
O86/CyO (kindly
provided by R. Ray [14]), KX43/TM6C, Dys8-2/TM3 [6], act-
Gal4/CyO, tub-Gal4/TM3, Ubi-GFP FRT42D,Dg
323/CyO, hsFLP;
FRT40A Ubi-GFP/CyO, hsFLP; FRT42D Ubi-GFP/CyO and hsFLP;
FRT82B/TM3. Alleles used in this study w[1118], msk[5], nAcRa-
30D[EY13897], fra[4], mbl[E27], sli[2], robo[2], lea[2], Sdc[10608],
stan[129], wg[spd-1], argos[Delta7] and Df(3R)Exel6184, the defi-
ciency for dystrophin were obtained from Bloomington Stock
Center.
The following Dys and Dg mutants were used to screen for
modifiers of the wing vein phenotype: Dys
E6, an hypomorphic
allele of dystrophin, act-Gal4:UAS-Dys
N-RNAi/CyO, tub-Gal4:UAS-
Dys
N2-RNAi/TM3, tub-Gal4:UAS-Dys
C-RNAi/TM3 which are three
Dys RNAi mutants recombined onto chromosomes with actin and
tubulin Gal4 drivers, respectively; and tub-Gal4:UAS-Dg
RNAi/TM3,
a Dg RNAi mutant recombined onto a chromosome with the
tubulin Gal4 driver. Dys
N-RNAi is a transgene on the second
chromosome that encodes an inverted repeat that forms a double
stranded RNA hairpin complementary to the corresponding N-
terminus of the protein. It reduces the protein levels of all the
known long isoforms. Dys
N2-RNAi is a transgene on the third
chromosome that encodes a different inverted repeat than Dys
N-
RNAi but still reduces the protein levels of the known long isoforms.
Dys
C-RNAi is a transgene on the third chromosome that encodes
sequence complementary to the corresponding C-terminal region
of dystrophin and reduces the protein levels of all isoforms. All Dys
RNAi mutants exhibited 100% penetrance of the wing vein
phenotype. The Dg RNAi mutant exhibited ,30% penetrance of
the wing vein phenotype.
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used in this study were obtained from the Kyoto Stock Center
(Japan). From this collection, 800 lines were screened. Two-to-four
day-old males carrying P-lethal insertions over balancers (or virgin
females if the P-element was on the X chromosome) were mated to
Dys
E6/TM3; act-Gal4:UAS-Dys
N-RNAi/CyO; tub-Gal4:UAS-Dys
C-RNAi/
TM3 and tub-Gal4:UAS-Dg
RNAi/TM3 virgin females (or males).
Non-balancer F1 progeny were screened for dominant
modification of the wing vein phenotype. Modifiers were divided
into phenotypic classes based on the alterations of their wing veins
as compared to wing veins of act-Gal4:UAS-Dys
N-RNAi/(+ or CyO),
tub-Gal4:UAS-Dys
C-RNAi/(+ or TM3) and tub-Gal4:UAS-Dg
RNAi/(+ or
TM3) sibling flies. Suppressors were identified when wing veins of
F1 flies phenocopied the wing veins seen in wild type flies. Since
Dys
E6/+ had wild-type wing veins, non-balancer F1 progeny from
the Dys
E6/TM3 and P-lethal insertion cross were analyzed for the
presence or absence of a mutant posterior crossvein which is
altered in Dys
E6 homozygotes. All the genes found in this screen
were crossed to w[1118] to verify the absence of a dominant wing
vein phenotype. None modifiers showed a dominant posterior
wing vein phenotype. Since P-element insertion lethal lines were
on chromosomes with FRT sites, we made mosaics and
determined if selected modifiers possessed an oocyte polarity
phenotype (see below).
EMS screen. For the EMS mutagenesis 2–4 day old w
1118
males were place in yeasted bottles overnight. Twenty males were
placed in each vial and starved for 6–8 hours. The flies were then
provided access to a solution of 22–25 mM EMS (ethyl
methansulfonate; Sigma) in a 5% sucrose solution for 18 hrs.
The flies were placed in new vials and allowed to recover for 1–
3 hrs. Each vial of flies was transferred to yeasted bottles with 40
virgin females of the desired genotype per bottle. The females were
allowed to lay eggs for two days then transferred to new bottles
daily for two more days. Mutagenized w
1118 males were crossed to
act-Gal4:UAS-Dys
N-RNAi/CyO or tub-Gal4:UAS-Dys
N2-RNAi/TM3
females. Males of these crosses were scored for a modification of
the wing vein phenotype, either a novel alteration or suppression.
These were picked and backcrossed to the parental Dystrophin
mutant females to determine whether the modification was on the
second or third chromosomes. Once this was done these modifiers
were balanced either with CyO or TM6B and maintained as a
stock. The subset of modifiers that produced phenotypes in the
absence of the Dys mutants were crossed to meiotic mapping stocks
and subsequently mapped using those phenotypes. The
remainders were crossed to meiotic mapping stocks with a
dystrophin mutant in the background and mapped using the
modification phenotypes. In addition to the two RNAi dystrophin
mutants mentioned above, enhancers of the Dys
E6 mutant were
also screened for.
Obtained modifiers were mapped meiotically using the lines
from Bloomington Stock Center al[1] dp[ov1] b[1] pr[1] c[1] px[1]
sp[1] and ru[1] h[1] th[1] st[1] cu[1] sr[1] e[s] ca[1].
Deficiency screen. A collection of 216 deficiency lines were
screened for modifiers of act-Gal4:UAS-Dys
N-RNAi/CyO mutant.
These lines were a mixed collection of flies from the Bloomington
Stock Center, the Exelixis (Harvard) and Drosdel (Cambridge)
collections. Additionally, these lines were used for mapping
modifiers (Mod29 and Mod4) from the EMS screen.
Deficiencies which show interaction in screen: w
*; Df(2L)spd
j2,
wg
spd-j2; w
1118; Df(2L)ade3; Df(2L)ED1473; Df(2R)ED2098;
Df(2R)en-B, b
1 pr
1; Df(2R)en-A; Df(2R)PC4; y
1w
*/Dp(1;Y)y
+;
Df(2R)P34; Df(3L)ED4978; Df(3R)ED5612; Df(3R)ED5942;
Df(3R)ED6025; Df(3R)ED6069; Df(3R)ED6076; Df(3R)ED6265;
Df(3R)Tl-P, e
1 ca
1.
Loss of Function Mosaic Analysis
To obtain germline clones of the modifiers found in the FRT P-
element lethal screen, they were crossed to corresponding
chromosomal FRT stocks. Third instar larvae and early pupae
from this cross were heat-shocked at 37uC for 2 hours. After
eclosion, they were placed in vials with fresh yeast paste for 4–
5 days before dissection.
Dissections and Immunohistochemistry
Drosophila ovaries and wing imaginal discs were dissected rapidly
in phosphate buffered saline (PBS) and fixed in 4% paraformal-
dehyde (PFA) for 10 minutes at room temperature. Adult’s brains
were dissected in PBS and fixed in PFA for 30 minutes. All
antibody stainings were performed as described previously [6],
except with the Dystrophin antibody with which a protocol
provided by L. Fradkin was used [62]. Ovaries, brains and wing
imaginal discs were mounted in 70% glycerol in PBS for analysis
using a Leica TSC SPE confocal microscope. The following
antibodies were used: rabbit anti-Dg (1:3000; [9]), anti-Dys CO2H
(1:3000; [62]), mouse anti-Orb (1:20; Developmental Studies
Hybridoma Bank), mouse anti-24B10 (1:20; Developmental
Studies Hybridoma Bank), Alexa 488, 568, or 633 goat anti-
mouse, Alexa 488, 568 goat anti rabbit. To mount adult wings,
flies were pre-incubated in 80% ethanol and 20% glycerol
solution, then dissected and mounted in 70% glycerol before
analysis using a Leica light microscope.
Muscle Analysis
Histological sections of muscle were prepared from wax-
embedded material as described previously [6], stained with
hematoxyline and eosin (H&E staining) and analyzed using light
microscopy.
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0002418.s001 (0.03 MB
DOC)
Table S1
Found at: doi:10.1371/journal.pone.0002418.s002 (0.14 MB
DOC)
Figure S1 Dys and Dg Expression in Wild Type and Mutant
Wing Discs. In wild-type larvae, Dys is expressed in all cells of the
wing disc (A) and is strongly reduced in the wing disc of the DysC-
RNAi mutant (B; tubGal4:UAS-DysC-RNAi/+). Dystroglycan
localization in wild type imaginal discs is enriched at the basal
surface of the epithelial cells. Dg expression is more intense in folds
formed from the contact of basal surfaces and is less visible in the
folds made from apical surfaces of wing disc cells (C). The
DgRNAi mutant also shows a reduction of Dystroglycan protein in
the wing disc (D; tub-Gal4:UAS-DgRNAi/+). (A9–D9) Enlarged
images of framed areas on (A–D). (A"–B") Enlarged images of
framed areas on (A–B) show Dystrophin single channel staining.
(C"–D") Enlarged images of framed areas on (C–D) show
Dystroglycan single channel staining.
Found at: doi:10.1371/journal.pone.0002418.s003 (6.06 MB TIF)
Figure S2 Subclasses of Dys(RNAi) Modifiers. (A) Example of
enhancers that lack the posterior cross vein (PCV) and belong to
phenotypic class En. Arrow indicates where the PCV should be.
(B) Wing representing Su+ class phenotype that shows the PCV
attached to L4 and L5 and extra wing vein material can be seen
below L5.
Found at: doi:10.1371/journal.pone.0002418.s004 (0.94 MB TIF)
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posterior cross veins. (A) Represents an enhancer (ModE10) of this
phenotype which phenocopies the wing veins from DysE6/DysE6
flies. (B) Shows an extra vein modification of the DysE6/+
posterior cross vein. Arrows indicate altered cross veins.
Found at: doi:10.1371/journal.pone.0002418.s005 (1.94 MB TIF)
Figure S4 Dg(RNAi) Modifiers. (A) Wild type fly wing with
normal posterior cross vein (PCV) as indicated by the arrow. (B)
DgRNAi mutant PCV (arrow) with a branch. (C–D) represent
modifiers that produce extra vein material (indicated by arrows. In
one case (C) the branch is elongated with extra material also seen
above L2 (upper arrow). (D) Shows extra material below L5 (lower
arrow).
Found at: doi:10.1371/journal.pone.0002418.s006 (1.77 MB TIF)
Figure S5 Phenotypes Observed in poly-EGF Mutants. (A) Fly
wing from Mod29/Df flies. Arrows indicate extra vein material.
(B) Transverse histological section of the indirect flight muscle in
Mod29 homozygotes. (B’) Higher magnification of the region
indicated by the box which indicates the separation of the muscle
into individual fibers. (C) Ovariole from a Mod29 homozygote.
Anterior to the left. The germarium is at the anterior most tip of
the ovariole with developing egg chambers progressing to the right
(posteriorly). The egg chambers undergo developmental arrest in
later stages. Actin-Green, Adducin-Red, DAPI-purple. (D) 24B10
antibody staining of the adult wild type brain. Arrows indicate
photoreceptor axon termination sites where the R8 photoreceptor
axon (left arrow) terminates before the R7 axon (right arrow). (E)
Mod29/Df adult brain. Termination of the R8 and R7 axons are
indicated by the red arrows. White arrows indicate non
termination of two axons that protrude deeper into the brain.
(F) Dg323/Dg323 clone in the adult brain. Red arrows indicate
where the R8 and R7 axons should terminate. Upper white arrows
indicate a general disruption of axon termination in the R8/R7
termination region. Lower right arrow indicates a non terminating
axon that proceeds deeper into the brain.
Found at: doi:10.1371/journal.pone.0002418.s007 (3.58 MB TIF)
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